The Tissue Protein Profiling/Imaging Shared Resource is a new Shared Resource that provides state-of-the-art instrumentation and skilled personnel for the acquisition of molecular weight coded protein profiles in a variety of normal and cancer tissues, including solid tissues (e.g., from brain, lung, breast, prostate, head and neck, and colon) and also fluids such as serum. Protein profiles are acquired using modern high sensitivity mass spectrometry technologies and, once processed, lead to the identification of a suite of molecular markers that can be used as an aid to the diagnosis of disease, assessment of specific disease subtypes, elucidation of disease progression, indication of prognosis, and determination of drug efficacy during and following treatment. As part of the discovery process aimed at the determination of the mechanism of disease, individual proteins previously measured by molecular weight can be rigorously identified through use of the protein identification service of the Proteomics Shared Resource, with which the Tissue Protein/Profiling/Imaging Shared Resource works closely. Dr. Richard Caprioli is the Director of the Shared Resource. He confers with investigators about their needs and devises advanced techniques and strategies for solving problems related to protein profiling. Dr. Daniel C. Liebler is Co-Director of the Tissue Protein Profiling/Imaging Shared Resource, Director of the Proteomics laboratory in the Mass Spectrometry Research Center, and is responsible for the direct supervision of the Resource.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA068485-09
Application #
6990127
Study Section
Subcommittee G - Education (NCI)
Project Start
2004-09-28
Project End
2009-08-31
Budget Start
2004-09-28
Budget End
2005-08-31
Support Year
9
Fiscal Year
2004
Total Cost
$149,052
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Maacha, Selma; Hong, Jun; von Lersner, Ariana et al. (2018) AXL Mediates Esophageal Adenocarcinoma Cell Invasion through Regulation of Extracellular Acidification and Lysosome Trafficking. Neoplasia 20:1008-1022
Schulte, Michael L; Fu, Allie; Zhao, Ping et al. (2018) Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models. Nat Med 24:194-202
Petersen, Christine P; Meyer, Anne R; De Salvo, Carlo et al. (2018) A signalling cascade of IL-33 to IL-13 regulates metaplasia in the mouse stomach. Gut 67:805-817
Wang, Jing; Zhao, Yue; Zhou, Xiaofan et al. (2018) Nascent RNA sequencing analysis provides insights into enhancer-mediated gene regulation. BMC Genomics 19:633
Galligan, James J; Wepy, James A; Streeter, Matthew D et al. (2018) Methylglyoxal-derived posttranslational arginine modifications are abundant histone marks. Proc Natl Acad Sci U S A 115:9228-9233
Davenport, James R; Su, Timothy; Zhao, Zhiguo et al. (2018) Modifiable lifestyle factors associated with risk of sessile serrated polyps, conventional adenomas and hyperplastic polyps. Gut 67:456-465
Pannala, Venkat R; Wall, Martha L; Estes, Shanea K et al. (2018) Metabolic network-based predictions of toxicant-induced metabolite changes in the laboratory rat. Sci Rep 8:11678
Zhao, Shilin; Li, Chung-I; Guo, Yan et al. (2018) RnaSeqSampleSize: real data based sample size estimation for RNA sequencing. BMC Bioinformatics 19:191
Croessmann, Sarah; Sheehan, Jonathan H; Lee, Kyung-Min et al. (2018) PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3K? Inhibitors. Clin Cancer Res 24:1426-1435
Doxie, Deon B; Greenplate, Allison R; Gandelman, Jocelyn S et al. (2018) BRAF and MEK inhibitor therapy eliminates Nestin-expressing melanoma cells in human tumors. Pigment Cell Melanoma Res 31:708-719

Showing the most recent 10 out of 2462 publications